Medicare NCD Topic Selection Still Needs More Clarity, Manufacturers Say
Executive Summary
CMS' reasons for selecting topics for a possible national coverage determination are sometimes unclear and even inconsistent with the agency's own guidance, the two major drug and biologic manufacturer associations are telling the agency